Stratos Wealth Advisors LLC Raises Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Stratos Wealth Advisors LLC lifted its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 8.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,192 shares of the company’s stock after acquiring an additional 1,133 shares during the quarter. Stratos Wealth Advisors LLC owned 0.22% of VanEck Pharmaceutical ETF worth $1,224,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Townsquare Capital LLC boosted its holdings in VanEck Pharmaceutical ETF by 3.8% during the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after buying an additional 130 shares in the last quarter. FMR LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after acquiring an additional 212 shares in the last quarter. Assetmark Inc. grew its holdings in shares of VanEck Pharmaceutical ETF by 5.8% in the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock worth $617,000 after acquiring an additional 354 shares during the period. Harbour Investments Inc. increased its stake in VanEck Pharmaceutical ETF by 16.6% in the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock valued at $325,000 after purchasing an additional 488 shares in the last quarter. Finally, Stifel Financial Corp raised its holdings in VanEck Pharmaceutical ETF by 13.4% during the third quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock worth $742,000 after purchasing an additional 924 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

PPH opened at $89.76 on Friday. VanEck Pharmaceutical ETF has a one year low of $84.48 and a one year high of $99.51. The company has a market cap of $555.61 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The business’s fifty day moving average is $87.78 and its two-hundred day moving average is $91.75.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were given a $0.411 dividend. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.